European Archives - Page 339 of 1177 - European Medical Journal

Improved Prostate Cancer Diagnosis with AI

New research has shown that an AI system can more efficiently detect clinically significant prostate cancer on MRI compared to radiologists.

Acalabrutinib and Chemotherapy Enhance Survival in Mantle Cell Lymphoma

Frontline treatment with acalabrutinib, bendamustine, and rituximab shows promising results in reducing disease progression and death in older mantle cell lymphoma patients.

TP53 Mutations: Key to CLL Progression and Treatment

Study reveals the significant impact of TP53 mutations on chronic lymphocytic leukaemia progression and survival, emphasising the importance of mutation type and treatment strategy

Vitamin C Associated with Improved Survival in Low-Risk Myeloid Malignancies

Results from a trial on the use of vitamin C supplementation for the treatment of low-risk myeloid malignancies were presented at the 2024 European Haematology Association Congress

Primary Ovarian Insufficiency Increases Risk for Reproductive Cancers

Females with primary ovarian insufficiency, experiencing menopause at ≤40 years, face a heightened risk for breast cancer, and ovarian cancer, according to new research.

Positron Emission Tomography Reliably Predicts Dementia Progression

Recent data demonstrated that tau positron emission tomography has significant prognostic value in predicting the progression from mild cognitive impairment to dementia.

Low-Fat, High-Fibre Diet Improves Crohn’s Disease Management

Recent research has highlighted the significant impact of a catered low-fat, high-fibre (LF/HF) diet on patients with Crohn’s disease.

AI-Assisted Navigation Shortens Referral Times for Pancreatic Cancer

AI-assisted navigation can enhance the coordination and delivery of specialty cancer services for patients with suspected pancreatic cancer, according to new research.

Evaluating Survival Outcomes of Systemic Anti-Cancer Therapy in Metastatic Cancer

Patients with certain cancers treated at practices using more systemic therapy did not have significantly improved survival outcomes compared to those treated at practices using less.

AI Analysis of Blood Tests Identifies Parkinson's Disease Years Before Motor Onset

Machine learning analysis of a panel of blood biomarkers accurately classified 79% of pre-motor patients up to seven years before the onset of motor symptoms.